• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS INC. ATELLICA IM BR 27.29 (BR); SYSTEM, TEST, IMMUNOLOGICAL, ANTIGEN, TUMOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS INC. ATELLICA IM BR 27.29 (BR); SYSTEM, TEST, IMMUNOLOGICAL, ANTIGEN, TUMOR Back to Search Results
Model Number N/A
Device Problem High Test Results (2457)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 08/09/2023
Event Type  malfunction  
Manufacturer Narrative
A customer from the united states obtained a falsely elevated br 27.29 (br) patient sample result on atellica im analyzer.The initial result was reported to the physician(s), who questioned the result.The same sample was measured on an alternate testing method (advia centaur) and the result was lower compared to the atellica im result.The interpretation of results section of the atellica im br 27.29 (br) instructions for use (ifu) states: "results of this assay should always be interpreted in conjunction with the patient's medical history, clinical presentation, and other findings." siemens healthcare diagnostics is investigating.
 
Event Description
The customer obtained a falsely elevated br 27.29 (br) patient sample result on atellica im analyzer.The initial result was reported to the physician(s), who questioned the result.The same sample was measured on an alternate testing method (advia centaur) and the result was lower compared to the atellica im result.There are no known reports of patient intervention or adverse health consequences due to the falsely elevated br 27.29 (br) result.
 
Manufacturer Narrative
Siemens filed the initial mdr 1219913-2023-00183 on 05-sep-2023.Additional information 24-jan-2024: a customer from the united states obtained a falsely elevated br 27.29 (br) patient sample result (55.06 u/ml) on atellica im analyzer.The initial result was reported to the physician(s), who questioned the result.The same sample was measured on an alternate testing method (advia centaur) and the result (34 u/ml) was lower compared to the atellica im result.Reviewing the data, siemens identified that the lot calibration used to generate the 55.06 u/ml result with sample 58596460 had not been verified with quality control (qc) in over a week.The qc that recovered acceptably prior to sample 58596460 used a different pack calibration but the 55.06 u/ml result was not generated with that pack.When the pack with the pack calibration used for qc was used up, the analyzer switched to using a different pack which did not have a pack calibration, so the analyzer defaulted to the lot calibration that was used to generate the 55.06 u/ml result.The qc the customer ran with the lot calibration after sample 58596460 was tested recovered high so the customer recalibrated.Siemens reviewed the calibrations and observed differences in relative light units (rlus).Siemens performed an offline calculation using the sample 58596460 relative light units with the new calibration and showed the sample 58596460 result would have been 34 u/ml if the br pack had been calibrated before testing the sample.Based on the available information, the cause of the difference in calibrator rlus between the lot calibration and the new calibration could not be determined but siemens cannot rule out reagent shipping/handling.The customer is operational.In section h6, the investigation finding, and investigation conclusion codes were updated.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ATELLICA IM BR 27.29 (BR)
Type of Device
SYSTEM, TEST, IMMUNOLOGICAL, ANTIGEN, TUMOR
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS INC.
511 benedict ave
tarrytown NY 10591 5097
Manufacturer (Section G)
SIEMENS HEALTHCARE DIAGNOSTICS INC.
333 coney st.
east walpole MA 02032
Manufacturer Contact
louise mclaughlin
333 coney st.
east walpole, MA 02032
7818564812
MDR Report Key17682479
MDR Text Key322626114
Report Number1219913-2023-00183
Device Sequence Number1
Product Code MOI
UDI-Device Identifier00630414598055
UDI-Public00630414598055
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K982680
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 02/14/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/23/2024
Device Model NumberN/A
Device Catalogue Number10995478
Device Lot Number269
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 08/23/2023
Initial Date FDA Received09/05/2023
Supplement Dates Manufacturer Received01/24/2024
Supplement Dates FDA Received02/14/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/23/2023
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-